scholarly journals EFFECTS OF ALEGLITAZAR ON CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH STAGE 3 CHRONIC KIDNEY DISEASE AND TYPE II DIABETES

2013 ◽  
Vol 61 (10) ◽  
pp. E1173 ◽  
Author(s):  
Klas Malmberg ◽  
Markolf Hanefeld ◽  
Luis Ruilope ◽  
A. Lincoff ◽  
Giancarlo Viberti ◽  
...  
PLoS ONE ◽  
2016 ◽  
Vol 11 (9) ◽  
pp. e0162782 ◽  
Author(s):  
Maria Alice Muniz Domingos ◽  
Silvia Regina Moreira ◽  
Luz Gomez ◽  
Alessandra Goulart ◽  
Paulo Andrade Lotufo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document